SPA.AU Spacetalk Ltd
Not Yet Opened 05-07 16:12:00 AEST
0.02
+0.00
-4.76%
High
0.02
Low
0.02
Vol
247.68K
Open
0.02
D1 Closing
0.02
Amplitude
0.00%
Mkt Cap
9.42M
Tradable Cap
6.61M
Total Shares
471.02M
T/O
4.95K
T/O Rate
0.07%
Tradable Shares
330.67M
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
seekingalpha · 04-23
Spero Therapeutics Delivers On Game Plan To Create Shareholder Value
Press Release: Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
Dow Jones · 04-22
Press Release: Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
BUZZ-Australia's COSOL jumps on acquiring asset management consultancy
Reuters · 04-19
BUZZ-Australia's COSOL jumps on acquiring asset management consultancy
Press Release: BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
Dow Jones · 04-17
Press Release: BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
BrainStorm gains as FDA OKs Phase 3 trial design for ALS therapy
seekingalpha · 04-09
BrainStorm gains as FDA OKs Phase 3 trial design for ALS therapy
Press Release: Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Dow Jones · 04-01
Press Release: Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
There's No Escaping Spacetalk Limited's (ASX:SPA) Muted Revenues
Simply Wall St. · 03-29
There's No Escaping Spacetalk Limited's (ASX:SPA) Muted Revenues
Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie
seekingalpha · 03-24
Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie
BRIEF-Spacetalk Ltd Says Tonderai Maenzanise To Step Down As CFO
Reuters · 03-15
BRIEF-Spacetalk Ltd Says Tonderai Maenzanise To Step Down As CFO
Saudi Aramco Eyes Q3 Start-up for Jazan 800 kt/year PX Unit -- OPIS
Dow Jones · 03-11
Saudi Aramco Eyes Q3 Start-up for Jazan 800 kt/year PX Unit -- OPIS
BUZZ-Australia's Metro Mining hits over 21-mnth high on FY24 forecast
Reuters · 02-29
BUZZ-Australia's Metro Mining hits over 21-mnth high on FY24 forecast
BRIEF-Spacetalk Says HY Loss Attributable A$4.0 Mln
Reuters · 02-29
BRIEF-Spacetalk Says HY Loss Attributable A$4.0 Mln
BRIEF-Spacetalk Ltd Says HY Annual Recurring Revenue (Arr) Increased 28% On The Prior Corresponding Period (“Pcp”) To A$9.5M
Reuters · 02-29
BRIEF-Spacetalk Ltd Says HY Annual Recurring Revenue (Arr) Increased 28% On The Prior Corresponding Period (“Pcp”) To A$9.5M
Press Release: Woodside Releases Full-Year 2023 Results
Dow Jones · 02-27
Press Release: Woodside Releases Full-Year 2023 Results
Georg Chmiel Bought 157% More Shares In Spacetalk
Simply Wall St. · 01-27
Georg Chmiel Bought 157% More Shares In Spacetalk
BRIEF-Spacetalk Posts Qtrly Group Revenue From Continuing Operations Of A$5.5M
Reuters · 01-23
BRIEF-Spacetalk Posts Qtrly Group Revenue From Continuing Operations Of A$5.5M
TMH Market Update: ASX200 edges lower on US inflation read
The Market Herald · 01-12
TMH Market Update: ASX200 edges lower on US inflation read
Load more
Introduction
Company Name.
Spacetalk Ltd
Affiliated Markets:
ASX
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"SPA.AU","market":"AU","secType":"STK","nameCN":"Spacetalk Ltd","latestPrice":0.02,"timestamp":1715062320000,"preClose":0.021,"halted":0,"volume":247681,"delay":0,"nameEN":"Spacetalk Ltd","floatShares":330674221,"shares":471021409,"eps":-0.026573,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"05-07 16:12:00 AEST","open":0.02,"high":0.02,"low":0.02,"amount":4954,"amplitude":0,"askPrice":0.021,"askSize":60000,"bidPrice":0.019,"bidSize":526315,"shortable":3,"etf":0,"ttmEps":-0.026573,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1715126400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.021,"openAndCloseTimeList":[[1715040000000,1715061600000]],"volumeRatio":0.508544,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/SPA.AU","defaultTab":"news","newsList":[{"id":"2429111214","title":"Spero Therapeutics Delivers On Game Plan To Create Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2429111214","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429111214?lang=en_us&edition=fundamental","pubTime":"2024-04-23 23:37","pubTimestamp":1713886637,"startTime":"0","endTime":"0","summary":"Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating landmark data with multi-bagger potential.Spero has excellen","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413265641/image_1413265641.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413265641/image_1413265641.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4685311-spero-therapeutics-delivers-on-game-plan-to-create-shareholder-value","is_publish_highlight":false,"gpt_icon":0},{"id":"2429405549","title":"Press Release: Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2429405549","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2429405549?lang=en_us&edition=fundamental","pubTime":"2024-04-22 20:00","pubTimestamp":1713787200,"startTime":"0","endTime":"0","summary":"FARMINGTON HILLS, Mich., April 22, 2024 -- Ocuphire Pharma, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that Daniel Su, M.D. will deliver a paper presentation on oral APX3330 at the Association for Research in Vision and Ophthalmology Annual Meeting to be held May 5-9, 2024 in Seattle, Washington.Key details about Dr. Su's presentation at the ARVO 2024 Annual Meeting are below:. Oral APX3330, a Ref-1 Inhibitor, Slows Progression of. In addition, Ocuphire has a partnership with Viatris to develop and commercialize Phentolamine Ophthalmic Solution 0.75% , a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size. PS was approved by the FDA for the treatment for pharmacologically-induced mydriasis under the brand name RYZUMVI in September 2023. PS is also in Phase 3 clinical development for the treatment of presbyopia and for the treatment","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2428571012","title":"BUZZ-Australia's COSOL jumps on acquiring asset management consultancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2428571012","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428571012?lang=en_us&edition=fundamental","pubTime":"2024-04-19 10:00","pubTimestamp":1713492032,"startTime":"0","endTime":"0","summary":"** Shares of asset management company COSOL rise as much as 1.5% to A$1.00 ** COS set for best week since March 29 ** Co says it entered into a binding Share Purchase Agreement to acquire asset management consultancy Core Asset Co for A$6.1 mln ** Stock down 0.5% so far this year, as of last close ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428381339","title":"Press Release: BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn","url":"https://stock-news.laohu8.com/highlight/detail?id=2428381339","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2428381339?lang=en_us&edition=fundamental","pubTime":"2024-04-17 06:31","pubTimestamp":1713306660,"startTime":"0","endTime":"0","summary":"BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn. Dr. Dagher has served as our Chief Development Officer since July 2023. In his new role as Executive Vice President and Chief Medical Officer, Dr. Dagher's responsibilities will include overseeing the planned Phase 3b registration trial of NurOwn. The Company recently announced that it has reached agreement with the U.S. Food & Drug Administration for a Special Protocol Assessment for this trial.Dr. Dagher has over 20 years' of experience in clinical research and development, with a proven track record of leading successful clinical trials and fostering innovation in drug development. Prior to joining Brainstorm he was Chief Medical Officer at Enveric Biosciences where he was responsible for defining the portfolio strategy and advancement of development plans toward regulatory approvals. He began his career in biopharmaceuticals as a medical scientist at GSK, and has se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2426864167","title":"BrainStorm gains as FDA OKs Phase 3 trial design for ALS therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2426864167","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2426864167?lang=en_us&edition=fundamental","pubTime":"2024-04-09 18:58","pubTimestamp":1712660304,"startTime":"0","endTime":"0","summary":"BrainStorm Cell Therapeutics traded higher in the premarket Tuesday after announcing that the U.S. FDA has endorsed the design of a late-stage trial for its cell therapy candidate NurOwn for amyotrophic lateral sclerosis, a neurological disease. The company said the regulator sent a written confirmation of a so-called Special Protocol Assessment , validating the critical trial components such as protocol and statistical analysis of its planned Phase 3b study. The two-part trial is expected to start in 2024 across multiple study sites for patients with ALS who are in the earlier stages of the disease. \"We believe that having this SPA in place will help de-risk certain regulatory aspects of the NurOwn clinical program,\" BrainStorm CEO Chaim Lebovits remarked. More on BrainStorm Cell Therapeutics BrainStorm submits SPA request to FDA for Phase 3 study design Seeking Alpha’s Quant Rating on BrainStorm Cell Therapeutics Historical earnings data for BrainStorm Cell Therapeutics Financ","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4088132-brainstorm-stock-gains-fda-oks-als-trial","is_publish_highlight":false,"gpt_icon":0},{"id":"2424792309","title":"Press Release: Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2424792309","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2424792309?lang=en_us&edition=fundamental","pubTime":"2024-04-01 19:00","pubTimestamp":1711969200,"startTime":"0","endTime":"0","summary":"Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient's own biology to deliver rare disease therapeutics, today provided an update on the company's development pipeline and reported financial results for the fourth quarter and fiscal year ended December 31, 2023.\"With the acquisition of EryDel S.p.A. in October last year, we have successfully shifted our strategic focus to become a Phase 3 biotechnology company dedicated to securing regulatory approval for our lead product, EryDex, for the treatment of patients with Ataxia-Telangiectasia (A-T),\" said Dirk Thye, M.D., Quince's Chief Executive Officer and Chief Medical Officer. \"With $75.1 million cash on hand, we expect to have sufficient funding to complete our Phase 3 clinical trial, in addition to supporting the expansion of EryDex into other indications and our Autologous Intracellular Drug Encapsulation technology platform into new products. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2423173176","title":"There's No Escaping Spacetalk Limited's (ASX:SPA) Muted Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2423173176","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2423173176?lang=en_us&edition=fundamental","pubTime":"2024-03-29 04:26","pubTimestamp":1711657573,"startTime":"0","endTime":"0","summary":"You may think that with a price-to-sales (or \"P/S\") ratio of 0.6x Spacetalk Limited ( ASX:SPA ) is definitely a stock...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-spa/spacetalk-shares/news/theres-no-escaping-spacetalk-limiteds-asxspa-muted-revenues","is_publish_highlight":false,"gpt_icon":0},{"id":"2421310935","title":"Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie","url":"https://stock-news.laohu8.com/highlight/detail?id=2421310935","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2421310935?lang=en_us&edition=fundamental","pubTime":"2024-03-24 12:46","pubTimestamp":1711255584,"startTime":"0","endTime":"0","summary":"Lead asset, reproxalap, has clear path to regulatory approval in Dry Eye Disease.Option deal for commercial license with AbbVie signed - $400M in milestones, 60/40 profit shares of US market and tiere","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397661322/image_1397661322.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1397661322/image_1397661322.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4680108-aldeyra-derisked-biotech-eyeing-path-to-approval-and-finalizing-deal-with-abbvie","is_publish_highlight":false,"gpt_icon":0},{"id":"2419553962","title":"BRIEF-Spacetalk Ltd Says Tonderai Maenzanise To Step Down As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2419553962","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2419553962?lang=en_us&edition=fundamental","pubTime":"2024-03-15 09:37","pubTimestamp":1710466648,"startTime":"0","endTime":"0","summary":"March 15 (Reuters) - Spacetalk Ltd : * TONDERAI MAENZANISE STEPS DOWN AS CFO * APPOINTMENT OF GERHARD BEUKES AS INTERIM CFOFurther company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418358443","title":"Saudi Aramco Eyes Q3 Start-up for Jazan 800 kt/year PX Unit -- OPIS","url":"https://stock-news.laohu8.com/highlight/detail?id=2418358443","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2418358443?lang=en_us&edition=fundamental","pubTime":"2024-03-11 19:28","pubTimestamp":1710156480,"startTime":"0","endTime":"0","summary":"Saudi Arabian Oil Co. is eyeing a start-up of its Jazan paraxylene unit in the third quarter of 2024, according to a market source on March 11.The company is making progress on its 800,000 metric tons per year PX plant, but there remains no official start-up timeline, according to the source.Market participants have been keeping a close watch on Jazan's progress, it being one of the few new PX plants yet to commence production.Jazan's PX unit was last expected to debut in June 2023, along with those from Sinopec, PetroChina, Cnooc, and Zhejiang Petrochemical in the same year, OPIS reported.\"Jazan's PX delay has to do with better margins in gasoline,\" said Duncan Clark, Vice President, and Global Aromatics & Fibers Team Lead at Chemical Market Analytics by OPIS.\"Aramco's overall PX operating rate is less than 60% at present,\" added Ashish Pujari, Vice President of Aromatics and Fibers at CMA.Aramco's Jazan PX unit has been delayed by over seven years, data from OPIS showed. The plan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2415551918","title":"BUZZ-Australia's Metro Mining hits over 21-mnth high on FY24 forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2415551918","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2415551918?lang=en_us&edition=fundamental","pubTime":"2024-02-29 11:06","pubTimestamp":1709176017,"startTime":"0","endTime":"0","summary":"** Shares of Metro Mining rise 6.9% to A$0.030, their highest since May 2022; last up 3.5% ** Bauxite miner sets forecast for production and shipment at 6.3 mln to 6.8 mln wet metric tonnes for 2024 ** Says underlying EBITDA improved to A$18.5 mln compared to loss of A$24.8 mln ** About 12 mln shares change hands, compared with the 30-day average volume of 6.6 mln shares ** Stock up 42.9% so far this year ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415653447","title":"BRIEF-Spacetalk Says HY Loss Attributable A$4.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2415653447","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2415653447?lang=en_us&edition=fundamental","pubTime":"2024-02-29 09:22","pubTimestamp":1709169728,"startTime":"0","endTime":"0","summary":"Feb 29 (Reuters) - Spacetalk Ltd : * LOSS FOR HALF-YEAR ATTRIBUTABLE A$4.0 MILLION VERSUS LOSS A$9.2 MILLION * HY REVENUE FROM ORDINARY ACTIVITIES A$9.4 MILLION VERSUS A$9.3 MILLIONSource text for Eikon: Further company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2415553688","title":"BRIEF-Spacetalk Ltd Says HY Annual Recurring Revenue (Arr) Increased 28% On The Prior Corresponding Period (“Pcp”) To A$9.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2415553688","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2415553688?lang=en_us&edition=fundamental","pubTime":"2024-02-29 08:27","pubTimestamp":1709166445,"startTime":"0","endTime":"0","summary":"Feb 29 - Spacetalk Ltd : * HY ANNUAL RECURRING REVENUE INCREASED 28% ON THE PRIOR CORRESPONDING PERIOD TO A$9.5M * IN HY ACTIVE SUBSCRIBER GROWTH FOR SPACETALK MOBILE GREW 272% ON PCP TO OVER 26,000 ACTIVE SUBSCRIBERSSource text for Eikon: Further company coverage: ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414864440","title":"Press Release: Woodside Releases Full-Year 2023 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2414864440","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2414864440?lang=en_us&edition=fundamental","pubTime":"2024-02-27 07:43","pubTimestamp":1708990980,"startTime":"0","endTime":"0","summary":"Woodside has achieved record production of 187.2 MMboe and excellent operated LNG reliability of 98%. We recorded full-year net profit after tax of $1,660 million, and underlying NPAT of $3,320 million when adjusted for exceptional items, and operating cash flow was $6,145 million.The Directors have determined a final dividend of US 60 cents per share , bringing the full-year dividend to US 140 cps. The dividend is fully franked. The value of the total full-year dividend is $2,658 million.Woodside CEO Meg O'Neill said she was tremendously proud that at a time of inflationary pressures, Woodside continued to return strong dividends to shareholders while delivering on our strategy to thrive through the energy transition.\"Our debt-free merger with BHP Petroleum added cash generating assets and strengthened Woodside's balance sheet, giving us capacity for future capital investments as well as ongoing returns. Gearing at year-end was 12.1% and our total available liquidity was $7.8 billio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2406024742","title":"Georg Chmiel Bought 157% More Shares In Spacetalk","url":"https://stock-news.laohu8.com/highlight/detail?id=2406024742","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2406024742?lang=en_us&edition=fundamental","pubTime":"2024-01-27 04:30","pubTimestamp":1706301034,"startTime":"0","endTime":"0","summary":"Potential Spacetalk Limited ( ASX:SPA ) shareholders may wish to note that the Independent Non-Executive Chairman...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4300003-choice1-main-header/1585186588101"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/software/asx-spa/spacetalk-shares/news/georg-chmiel-bought-157-more-shares-in-spacetalk","is_publish_highlight":false,"gpt_icon":0},{"id":"2405323041","title":"BRIEF-Spacetalk Posts Qtrly Group Revenue From Continuing Operations Of A$5.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2405323041","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2405323041?lang=en_us&edition=fundamental","pubTime":"2024-01-23 06:29","pubTimestamp":1705962543,"startTime":"0","endTime":"0","summary":"Jan 23 (Reuters) - Spacetalk Ltd : * QTRLY GROUP REVENUE FROM CONTINUING OPERATIONS INCREASED 6% TO A$5.5M * QTRLY ARR INCREASED 28% VERSUS PCP TO A$9.5MSource text for Eikon: ther company coverage: ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402599792","title":"TMH Market Update: ASX200 edges lower on US inflation read","url":"https://stock-news.laohu8.com/highlight/detail?id=2402599792","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2402599792?lang=en_us&edition=fundamental","pubTime":"2024-01-12 11:46","pubTimestamp":1705031160,"startTime":"0","endTime":"0","summary":"The ASX is trading down about .2 of a per cent this morning with 9 of the 11 sectors in negative territory.The subdued start to Friday trades follows a hotter-than-expected inflation read from the US overnight, lifting doubts that the Federal Reserve will cut rates as early as expected.Tesla has suspended production at its Berlin factory from January 29 to February 11, citing disruptions in transport routes caused by the ongoing Red Sea attacks.Child safety and communications tech company Spacetalk has lost more than three per cent after reporting a 77 per cent surge in Mobile active subscribers, totalling more than 26,000, as of December 31, 2023.Gold and base metals explorerRincon Resources has fallen nearly 16 per cent towards its raised price of 3.3 cents after securing $1.43 million through an oversubscribed placement. The funds raised are for the expansion of the ongoing drill program at its West Arunta project in Western Australia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketherald.com.au/tmh-market-update-asx200-edges-lower-on-us-inflation-read-2024-01-12/","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mgmwireless.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0455},{"period":"3month","weight":0.05},{"period":"6month","weight":0},{"period":"1year","weight":-0.4615},{"period":"ytd","weight":-0.1923}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0409},{"period":"3month","weight":0.0717},{"period":"6month","weight":0.1242},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0928}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.070157},{"month":2,"riseRate":0.25,"avgChangeRate":0.028846},{"month":3,"riseRate":0.5,"avgChangeRate":-0.026618},{"month":4,"riseRate":0,"avgChangeRate":-0.18478},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.035986},{"month":6,"riseRate":0.666667,"avgChangeRate":0.065392},{"month":7,"riseRate":0.666667,"avgChangeRate":0.035088},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.054579},{"month":9,"riseRate":0,"avgChangeRate":-0.102484},{"month":10,"riseRate":0,"avgChangeRate":-0.166005},{"month":11,"riseRate":0.25,"avgChangeRate":0.013321},{"month":12,"riseRate":0.5,"avgChangeRate":0.063882}],"exchange":"ASX","name":"Spacetalk Ltd","nameEN":"Spacetalk Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spacetalk Ltd(SPA.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Spacetalk Ltd(SPA.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Spacetalk Ltd,SPA.AU,Spacetalk Ltd股票,Spacetalk Ltd股票老虎,Spacetalk Ltd股票老虎国际,Spacetalk Ltd行情,Spacetalk Ltd股票行情,Spacetalk Ltd股价,Spacetalk Ltd股市,Spacetalk Ltd股票价格,Spacetalk Ltd股票交易,Spacetalk Ltd股票购买,Spacetalk Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spacetalk Ltd(SPA.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Spacetalk Ltd(SPA.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}